SCHEMBL3718525

SCHEMBL3718525

CC(C)(C)n1ccc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.43
NPC1 O15118 8/20 0.40
RAB9A P51151 8/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
MAPT P10636 4/20 0.40
TP53 P04637 2/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
MEN1 O00255 1/20 0.38
F2RL3 Q96RI0 1/20 0.38
PKM P14618 1/20 0.37
DAPK3 O43293 1/20 0.36
RIPK2 O43353 1/20 0.36
ABL1 P00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3791987 0.83 KEAP1 (0.44) KEAP1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL27009238 0.81 SCN4A (0.51) KEAP1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL13045974 0.81 KMT2A (0.59) KEAP1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL26251788 0.80 NPC1 (0.43) NPC1RAB9AMAPTGAAF2RL3
SCHEMBL2615403 0.76 KEAP1 (0.64) KEAP1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL26251804 0.75 KCNH2 (0.38) KEAP1NPC1RAB9AKMT2AMEN1
SCHEMBL4313599 0.75 SCN4A (0.48) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL28088809 0.71 RAB9A (0.43) KEAP1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3447669 0.70 KMT2A (0.48) KEAP1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL13273051 0.70 DYRK1A (0.44) KEAP1NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217239-A2 MODULATION OF PROTEIN TRAFFICKING Foldrx Pharmaceuticals, Inc. (US) 2010-08-18 EP disclosed
WO-2009062118-A2 MODULATION OF PROTEIN TRAFFICKING FOLDRX PHARMACEUTICALS, INC. (US) 2009-05-14 WO disclosed